François A. Auger

Publications récentes

Picard-Deland M., Ruel J., Galbraith T., Tremblay C., Kawecki F., Germain L., Auger FA. (2016) Tissue-Engineered tubular heart valves combining a novel precontraction phase with the self-assembly method". Annals of Biomedical Engineering.

Tondreau M.Y., Laterreur V., Vallières K., Gauvin R., Bourget JM., Tremblay C., Lacroix D., Germain L., Ruel J., Auger FA. (2016) In vivo remodeling of fibroblast-derived vascular scaffolds implanted for 6 months in rats. BioMed Research International.

Tondreau, M.Y., Laterreur, V., Gauvin, R., Vallières, K., Bourget, J.-M.M., Lacroix, D., Tremblay, C., Germain, L., Ruel, J., and Auger, F.A.A. (2015). Mechanical properties of endothelialized fibroblast-derived vascular scaffolds stimulated in a bioreactor. Acta Biomater 18, 176–185.

Vallières, K., Laterreur, V., Tondreau, M.Y., Ruel, J., Germain, L., Fradette, J., and Auger, F.A.A. (2015). Human adipose-derived stromal cells for the production of completely autologous self-assembled tissue-engineered vascular substitutes. Acta Biomater 24, 209–219.

Gibot, L., Chabaud, S., Bouhout, S., Bolduc, S., Auger, F.A.A., and Moulin, V.J.J. (2015). Anticancer properties of chitosan on human melanoma are cell line dependent. Int. J. Biol. Macromol. 72, 370–379.

Dubé, J., Bourget, J.-M.M., Gauvin, R., Lafrance, H., Roberge, C.J., Auger, F.A.A., and Germain, L. (2014). Progress in developing a living human tissue-engineered tri-leaflet heart valve assembled from tissue produced by the self-assembly approach. Acta Biomater 10, 3563–3570.

Hayward, C.J., Fradette, J., Morissette Martin, P., Guignard, R., Germain, L., and Auger, F.A.A. (2014). Using human umbilical cord cells for tissue engineering: a comparison with skin cells. Differentiation 87, 172–181.

Tremblay, C., Ruel, J., Bourget, J.-M.M., Laterreur, V., Vallières, K., Tondreau, M.Y., Lacroix, D., Germain, L., and Auger, F.A.A. (2014). A new construction technique for tissue-engineered heart valves using the self-assembly method. Tissue Eng Part C Methods 20, 905–915.

Gibot, L., Galbraith, T., Huot, J., and Auger, F.A.A. (2013). Development of a tridimensional microvascularized human skin substitute to study melanoma biology. Clin. Exp. Metastasis 30, 83–90.

Hayward, C.J., Fradette, J., Galbraith, T., Rémy, M., Guignard, R., Gauvin, R., Germain, L., and Auger, F.A.A. (2013). Harvesting the potential of the human umbilical cord: isolation and characterisation of four cell types for tissue engineering applications. Cells Tissues Organs (Print) 197, 37–54.

Boa, O., Cloutier, C.B., Genest, H., Labbé, R., Rodrigue, B., Soucy, J., Roy, M., Arsenault, F., Ospina, C.E., Dubé, N., et al. (2013). Prospective study on the treatment of lower-extremity chronic venous and mixed ulcers using tissue-engineered skin substitute made by the self-assembly approach. Adv Skin Wound Care 26, 400–409.

Bourget, J.-M.M., Gauvin, R., Larouche, D., Lavoie, A., Labbé, R., Auger, F.A.A., and Germain, L. (2012). Human fibroblast-derived ECM as a scaffold for vascular tissue engineering. Biomaterials 33, 9205–9213.

Auger, F.A.A., Gibot, L., and Lacroix, D. (2013). The pivotal role of vascularization in tissue engineering. Annu Rev Biomed Eng 15, 177–200.